Clinical Trial Update: Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial of ABT-333 was conducted in healthy volunteers and Hepatitis C genotype 1 infected subjects; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-333 (ABT-333)

Snippet

Sponsor: AbbVie | Conditions: HCV Infection | Phase 1 | Status: COMPLETED